Scott Halpern Wins 2017 ACTS and AFMR Top Investigator Awards
The Association of Clinical and Translational Science and the American Federation of Medical Research have named Scott Halpern winner of both the 2017 AFMR Outstanding Investigator Award and the 2017 ACTS Distinguished Investigator Award.
Halpern, MD, PhD, is an Associate Professor in the Medicine, Epidemiology, and Medical Ethics and Health Policy departments of Penn's Perelman School of Medicine and an LDI Senior Fellow. He is the founding Director of the FIELDS End-of-Life Decision Science Center, Deputy Director of LDI's Center for Health Incentives and Behavioral Economics (CHIBE), and Director of Penn's Acute Care Health Services Research Group.
'Public Benefit and Policy'
The ACTS award cites Halpern's work for "translation from Clinical Use Into Public Benefit and Policy."
The AFMR honor annually singles out a person age 45 or younger judged to be the most outstanding medical scientist in any field.
Both awards will be presented at the joint ACTS-AFMR Translational Science 2017 meeting in Washington, D.C., next month.
The AFMR is a 77-year-old international association of scientists engaged in all areas of biomedical and health services research.
'Remarkable scientific innovations'
The 11-year-old ACTS awards were launched by the Director of the National Institutes of Health to highlight the outstanding efforts of scientists working to "translate the remarkable scientific innovations we are witnessing into health gains for the nation."
Previous Penn winners of the AFMR Outstanding Investigator Award include Rachel Werner, Katrina Armstrong, Jonathan Epstein, Mitchell Lazar and David Asch. Previous Penn winners of the ACTS Distinguished Investigaor Award include Kevin Volpp, Brian Strom, Francis Marchlinski, Stanley Plotkin, and Garret Fitzgerald.